Expert Spotlight: Sam Tom
As a child, Sam Tom, Vice President of Kelly Science & Clinical, concluded that the impossible could be achieved through science. This realization drove him to earn a bachelor's degree in Biology and Chemistry from Cornell University, a master's and doctoral degrees in biochemistry from the University of Rochester, and a Master of Business Administration degree from Johns Hopkins University. For the last 20+ years, Tom has led the development and commercialization of advanced biologics, drugs, devices, and tissue-based products for various companies, including a large pharmaceutical. And he has made the impossible possible with science, as an inventor on more than 20 issued patents and patent applications describing first-in-class products, including Prochymal® (remestemcel-L), the world's first approved drug with a stem cell as its active ingredient.
Becoming A Scientist
Something super gave Tom his passion for science.
Tom talks about what’s next in science.
We offer a variety of solutions that help throughout every stage of the drug and device lifecycle.
Clinical Research Diversity
As an Association of Clinical Research Professionals Premier Partner in Workforce Advancement, we will develop a more diverse clinical research workforce, which will help address long-standing healthcare disparities.
With our help, you can be the scientist you’ve always wanted to be.